← Back to patent-cliff list
Technetium [99mTc] Pentetate
Tier C — Watch / tradeTechnetium [99mTc] Pentetate
-
Originator
1997
First approval
-
Expiry (public)
No sales data
Peak sales
Radiopharmaceutical
Type
Targets：Not applicable
Indications (approved)：Kidney disease
Regional status
US
-
EU
-
China
Approved
1997-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Technetium [99mTc] Pentetate?
Approved indications include: Kidney disease.
When does the Technetium [99mTc] Pentetate patent expire?
No public expiry year is available for Technetium [99mTc] Pentetate yet; this page updates once verified.
How do I get a quote for Technetium [99mTc] Pentetate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27